Becton Dickinson (LTS:0R19) OCF Margin %: 12.73% (As of Mar. 2026) — 33% Below Median


LTS:0R19 Becton Dickinson & Co LTS:0R19
76 GF Score
Price $145.59
GF Value $190.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson OCF Margin %?

Becton Dickinson LTS:0R19 +2.75% 76 OCF Margin % is 12.73% as of Mar. 2026, which is 33% below its 10-year median of 19.04. GuruFocus rates LTS:0R19 with a GF Score™ of 76/100 and a GF Value™ of $190.16 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Becton Dickinson ranks better than 74.23% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Becton Dickinson's Cash Flow from Operations for the three months ended in Mar. 2026 was $600 Mil. Becton Dickinson's Revenue for the three months ended in Mar. 2026 was $4,714 Mil. Therefore, Becton Dickinson's OCF Margin % for the quarter that ended in Mar. 2026 was 12.73%.

As of today, Becton Dickinson's current OCF Yield % is 9.66%.

The historical rank and industry rank for Becton Dickinson's OCF Margin % or its related term are showing as below:

LTS:0R19' s OCF Margin % Range Over the Past 10 Years
Min: 13.95   Med: 19.04   Max: 24.3
Current: 17.93


During the past 13 years, the highest OCF Margin % of Becton Dickinson was 24.30%. The lowest was 13.95%. And the median was 19.04%.

LTS:0R19's OCF Margin % is ranked better than
74.23% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs LTS:0R19: 17.93


Becton Dickinson OCF Margin % Related Terms


Becton Dickinson OCF Margin % Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson OCF Margin % Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.30 13.95 15.43 18.82 15.71

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 22.15 23.00 12.49 12.73

LTS:0R19 vs MDLN, RMD, WST: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's OCF Margin % falls into.


LTS:0R19
76GF Score
Becton Dickinson & Co LTS:0R19
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Becton Dickinson's OCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=3431/21840
=15.71 %

Becton Dickinson's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=600/4714
=12.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 12.73% mean?
Becton Dickinson (LTS:0R19) has a OCF Margin % of 12.73% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Becton Dickinson and its competitors. This is 33% below median its historical median of 19.04. Over the past decade, Becton Dickinson's OCF Margin % has ranged from 13.95 to 24.30. According to the industry distribution chart, Becton Dickinson ranks #210 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 25.8%.
Is Becton Dickinson's OCF Margin % too high?
Becton Dickinson's current OCF Margin % of 12.73% is 33% below median its 10-year median of 19.04. Over the past 10 years, this metric has ranged from a low of 13.95 to a high of 24.30. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Becton Dickinson's value of 12.73% is 117.2% above this industry median. Based on the distribution chart, Becton Dickinson ranks #210 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's OCF Margin % compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #210 out of 815 companies for OCF Margin %. This puts Becton Dickinson in the upper half of its industry. The industry median OCF Margin % is 5.86. Becton Dickinson's value of 12.73% is 117.2% above this benchmark. Historically, Becton Dickinson's own OCF Margin % has ranged from 13.95 to 24.30 over the past decade. While the company's 10-year median is 19.04 vs. the industry median of 5.86, Becton Dickinson has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current OCF Margin % of 12.73% is 117.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current OCF Margin % is 12.73%, which is 33% below median its own 10-year median of 19.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (LTS:0R19) is currently considered Modestly Undervalued. The stock's GF Value™ is $190.16, compared to a current price of $145.59 — trading 23.4% below its estimated fair value. The current OCF Margin % is 12.73%, which is 33% below median its 10-year median of 19.04 and 117.2% above the Medical Devices & Instruments industry median of 5.86. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Becton Dickinson (LTS:0R19), the current OCF Margin % is 12.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (LTS:0R19) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $145.59 is trading 23.4% below its estimated GF Value™ of $190.16. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for LTS:0R19:

  • OCF Margin %: 12.73% (33% below median its 10-year median of 19.04)
  • GF Value™: $190.16 vs. price of $145.59 (23.4% below fair value)
  • GF Score™: 76/100 with 3 warning signs
  • Industry Position: 117.2% above the Medical Devices & Instruments median (#210 of 815)

No single metric tells the full story. See the LTS:0R19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for LTS:0R19

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$145.59
Price
$190.16
GF Value